Technical Analysis for INDV - Indivior PLC
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | -3.01% | |
| Pocket Pivot | Bullish Swing Setup | -3.01% | |
| Up 3 Days in a Row | Strength | -3.01% | |
| Stochastic Buy Signal | Bullish | -1.78% | |
| Pocket Pivot | Bullish Swing Setup | -1.78% | |
| Inside Day | Range Contraction | -1.78% | |
| Gapped Down | Weakness | -1.78% | |
| Lower Bollinger Band Touch | Weakness | -1.78% | |
| Oversold Stochastic | Weakness | -1.78% | |
| Slingshot Bearish | Bearish Swing Setup | -1.60% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Gapped Down (Full) | 24 minutes ago |
| 2x Volume Pace | 24 minutes ago |
| 1.5x Volume Pace | 24 minutes ago |
| Down 3% | 24 minutes ago |
| Fell Below Lower Bollinger Band | 24 minutes ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/02/2023
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Drugs Psychoactive Drugs Euphoriants Opioids Schizophrenia Morphinans Drug Rehabilitation Opioid Use Disorder Buprenorphine Sodium Channel Blockers
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Drugs Psychoactive Drugs Euphoriants Opioids Schizophrenia Morphinans Drug Rehabilitation Opioid Use Disorder Buprenorphine Sodium Channel Blockers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.8999 |
| 52 Week Low | 21.13 |
| Average Volume | 12,976 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 22.85 |
| 20-Day Moving Average | 22.33 |
| 10-Day Moving Average | 22.20 |
| Average True Range | 0.71 |
| RSI (14) | 48.45 |
| ADX | 12.57 |
| +DI | 21.50 |
| -DI | 23.32 |
| Chandelier Exit (Long, 3 ATRs) | 21.77 |
| Chandelier Exit (Short, 3 ATRs) | 23.25 |
| Upper Bollinger Bands | 23.06 |
| Lower Bollinger Band | 21.61 |
| Percent B (%b) | 0.47 |
| BandWidth | 6.49 |
| MACD Line | -0.22 |
| MACD Signal Line | -0.20 |
| MACD Histogram | -0.0121 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 23.10 | ||||
| Resistance 3 (R3) | 23.04 | 22.72 | 22.96 | ||
| Resistance 2 (R2) | 22.72 | 22.51 | 22.74 | 22.92 | |
| Resistance 1 (R1) | 22.50 | 22.38 | 22.61 | 22.56 | 22.87 |
| Pivot Point | 22.18 | 22.18 | 22.23 | 22.20 | 22.18 |
| Support 1 (S1) | 21.96 | 21.97 | 22.07 | 22.02 | 21.71 |
| Support 2 (S2) | 21.64 | 21.84 | 21.67 | 21.66 | |
| Support 3 (S3) | 21.42 | 21.64 | 21.62 | ||
| Support 4 (S4) | 21.48 |
